From: Which nasopharyngeal cancer patients need adaptive radiotherapy?
Variables | Number | Median (mean ± SD) |
---|---|---|
Female/male | 11 / 29 | Â |
Age (y/o) |  | 48.5 (49.1 ± 11.8) |
T Stage* | ||
 T1/T2 | 8/5 |  |
 T3/4 | 19 / 8 |  |
N Stage* | Â | Â |
 N0/1 | 3 / 9 |  |
 N2/N3a/N3b | 23 / 1 / 4 |  |
Stage* | ||
 I/II/III | 0 / 6 / 23 |  |
 IVa/IVb | 6 / 5 |  |
CCRT+neo-adj / CCRT | 31 / 9 | Â |
Fractions of 2nd CT scan |  | 22.0 (22.2 ± 1.8) |
ART boost plans (Gy) |  | 16.0 (15.6 ± 1.6) |
Total PTV-1 dose (Gy) |  | 72.0 (71.6 ± 1.2) |